Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I.
Yulong XuYiming XuSavannah BibyPing BaiYan LiuCan Martin ZhangChangning WangShijun ZhangPublished in: ACS chemical neuroscience (2021)
Mitochondrial dysfunction has been indicated in neurodegenerative and other disorders. The mitochondrial complex I (MC-I) of the electron transport chain (ETC) on the inner membrane is the electron entry point of the ETC and is essential for the production of reactive oxygen species. Based on a recently identified β-keto-amide type MC-I modulator from our laboratory, an 18F-labeled positron emission tomography (PET) tracer, 18F-2, was prepared. PET/CT imaging studies demonstrated that 18F-2 exhibited rapid brain uptake without significant wash out during the 60 min scanning time. In addition, the binding of 18F-2 was higher in the regions of the brain stem, cerebellum, and midbrain. The uptake of 18F-2 can be significantly blocked by its parent compound. Collectively, the results strongly suggest successful development of MC-I PET tracers from this chemical scaffold that can be used in future mitochondrial dysfunction studies of the central nervous system.
Keyphrases
- positron emission tomography
- pet ct
- computed tomography
- pet imaging
- high resolution
- reactive oxygen species
- oxidative stress
- white matter
- resting state
- electron microscopy
- case control
- cerebral ischemia
- current status
- photodynamic therapy
- solar cells
- tissue engineering
- blood brain barrier
- dna binding
- subarachnoid hemorrhage
- electron transfer